Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

830
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
830
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

617
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
617
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

631
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
631
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

433
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
433
Cancer Survival Analysis01:21

Cancer Survival Analysis

774
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
774
Relative Motion Analysis - Acceleration01:10

Relative Motion Analysis - Acceleration

901
A slider-crank mechanism converts rotational motion from the crank into linear motion of the slider or vice versa. This mechanism consists of three main parts: the crank, the connecting rod, and the slider. The movement of the slider-crank is an example of general plane motion as the fluctuating angle between the crank and the connecting rod. Consider a segment AB where point A is at the end of the slider and point B is on the diametrically opposite end to point A, on a crack. The variance in...
901

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-marketing safety surveillance of ado-trastuzumab emtansine: a real-world data retrospective cohort study using disproportionality analysis.

Expert opinion on drug safety·2024
Same author

Toward stakeholders' understanding of media reporting on doctor-patient relationship issues: trust, unfamiliarity and uncertainty in the Chinese context.

Frontiers in public health·2024
Same author

Large Language Model Enhanced Logic Tensor Network for Stance Detection.

Neural networks : the official journal of the International Neural Network Society·2024
Same author

Correction to "A Double Network Composite Hydrogel with Self-Regulating Cu<sup>2+</sup>/Luteolin Release and Mechanical Modulation for Enhanced Wound Healing".

ACS nano·2024
Same author

Comparison of robotic-assisted and laparoscopic partial nephrectomy based on the PADUA score and the predictive value of the PADUA score and the Mayo Adhesive Probability score for postoperative complications: a single-center retrospective study.

Journal of cancer research and clinical oncology·2024
Same author

LSD1 Demethylates and Destabilizes Autophagy Protein LC3B in Ovarian Cancer.

Biomolecules·2024

Related Experiment Video

Updated: Feb 11, 2026

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

3.5K

Robust sparse accelerated failure time model for survival analysis.

Haiwei Shen, Hua Chai, Meiping Li

    Technology and Health Care : Official Journal of the European Society for Engineering and Medicine
    |April 26, 2018
    PubMed
    Summary

    This study introduces a robust sparse accelerated failure time (RS-AFT) model for analyzing gene expression data in cancer survival analysis. The new method improves biomarker gene selection and survival time estimation, outperforming existing techniques.

    Keywords:
    AFTregularizationsurvival analysis

    More Related Videos

    Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
    05:18

    Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

    Published on: July 22, 2016

    8.9K
    A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail
    10:10

    A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail

    Published on: February 3, 2016

    13.9K

    Related Experiment Videos

    Last Updated: Feb 11, 2026

    Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
    09:02

    Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

    Published on: February 20, 2021

    3.5K
    Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
    05:18

    Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

    Published on: July 22, 2016

    8.9K
    A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail
    10:10

    A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail

    Published on: February 3, 2016

    13.9K

    Area of Science:

    • Bioinformatics
    • Computational Biology
    • Genomics

    Background:

    • High-dimensional, low-sample size gene expression data presents challenges for identifying disease-related biomarker genes.
    • Existing regression and regularization methods are often hindered by noise in biological data.

    Purpose of the Study:

    • To develop a novel robust sparse accelerated failure time (RS-AFT) model for improved gene selection and survival time estimation in cancer.
    • To address the limitations of existing methods in handling noisy biological data.

    Main Methods:

    • Proposed a robust sparse accelerated failure time (RS-AFT) model by integrating least absolute deviation (LAD) and Lq regularization.
    • Developed an iterative weighted linear programming algorithm for solving the RS-AFT model without requiring regularization parameter tuning.

    Main Results:

    • The RS-AFT model demonstrated superior performance in both gene selection and survival time estimation compared to widely used methods like LASSO, Elastic Net, and SCAD.
    • Experimental results validate the effectiveness of the proposed robust approach.

    Conclusions:

    • The novel RS-AFT model offers a competitive and robust regularization method for cancer survival analysis.
    • This approach enhances the identification of critical biomarker genes and improves survival prediction accuracy.